RADIATION: Total-Body Irradiation
DRUG: Thiotepa
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Busulfan
PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Tacrolimus
DRUG: Methotrexate
PROCEDURE: Naive T Cell-Depleted Hematopoietic Stem Cell Transplantation
PROCEDURE: Echocardiography
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Cyclophosphamide
DRUG: Cyclosporine
BIOLOGICAL: Filgrastim
DRUG: Fludarabine
DRUG: Mycophenolate Mofetil
DRUG: Mycophenolate Sodium
RADIATION: Total-Body Irradiation
DRUG: Treosulfan
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Peripheral Blood Stem Cell Transplant
DRUG: Allopurinol 300 MG
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: Bone Marrow Cell Transplant
RADIATION: Total Body Irradiation
DRUG: Sirolimus Pill
DRUG: Mycophenolate Mofetil
DRUG: AVM0703
DRUG: CD22CART Infusion
DRUG: Venetoclax
DRUG: Ibrutinib
DRUG: Prednisone
BIOLOGICAL: Obinutuzumab
DRUG: Revlimid (lenalidomide)
BIOLOGICAL: Zilovertamab vedotin
DRUG: Polatuzumab vedotin
BIOLOGICAL: obinutuzumab
DRUG: prednisone
DRUG: Revlimid
BIOLOGICAL: Polatuzumab
DRUG: ibrutinib
DRUG: venetoclax
DRUG: Fludarabine
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Cyclosporine A
DRUG: Mycophenylate mofetil
BIOLOGICAL: Umbilical cord blood
DRUG: SGR-1505
DRUG: IMT-009
COMBINATION_PRODUCT: Fruquintinib
DRUG: Bortezomib
DRUG: Clofarabine
DRUG: Cyclophosphamide
DRUG: Dexamethasone
DRUG: Etoposide
BIOLOGICAL: Ofatumumab
BIOLOGICAL: Pegfilgrastim
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate Liposome
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: anti-CD19 CAR-T cells
DEVICE: Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
DEVICE: CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
DRUG: Relatlimab
DRUG: Nivolumab
BIOLOGICAL: Blinatumomab
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
BIOLOGICAL: Inotuzumab Ozogamicin
OTHER: Laboratory Biomarker Analysis
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine
DRUG: Obinutuzumab
DRUG: Liposomal ARA-C
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide
BIOLOGICAL: HSCT with TBI Regimen
BIOLOGICAL: HSCT with Non-TBI Regimen
DRUG: Epcoritamab
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Rituximab
DRUG: Vincristine
DRUG: Prednisone
DRUG: Loncastuximab Tesirine 0.075 mg/kg by IV
DRUG: Loncastuximab tesirine 0.12 mg/kg by IV
DRUG: Loncastuximab tesirine 0.15 mg/kg by IV
Get the latest thought leadership on your Burkitt Lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.